Artelo Biosciences (ARTL) Shares Outstanding (Entity) (2014 - 2026)
Artelo Biosciences' Shares Outstanding (Entity) was 19,924 in Q2 2024, up 13.0% from 17,628 a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Artelo Biosciences (ARTL) Shares Outstanding (Entity) (2014 - 2026) Analysis & Trends
For FY2023, Shares Outstanding (Entity) at Artelo Biosciences came in at 19,685, up 11.7% from FY2022.
- Shares Outstanding (Entity) shows a five-year compound annual growth rate of 93.8% (FY2018 to FY2023).
- In earlier years, Shares Outstanding (Entity) was 17,628 in FY2022 (+59.1%), 11,080 in FY2021, 1,526 in FY2020 (+70.7%) and 894.00 in FY2019 (+24.2%).
- Compared with a year earlier, Shares Outstanding (Entity) has increased for six straight quarters, with growth averaging 8.4% over the last six quarters.
- The best year-over-year quarter for Shares Outstanding (Entity) over five years was Q3 2021 (growth of 519.8%); the worst was Q3 2019 (a decline of 1.4%).
- Per Business Quant data, ARTL's Shares Outstanding (Entity) in the three quarters before Q2 2024 was 19,924 (Q1 2024), 19,685 (Q4 2023) and 19,521 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 940.75 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.47 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 540.90 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.24 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.70 Bn |
| 10 | Artelo Biosciences | 49.32 Mn | 32.53 Mn | - | 22.84 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 22.84 Mn |
| Mar 31, 2026 | 22.84 Mn |
| Jun 30, 2024 | 19,924.00 |
| Mar 31, 2024 | 19,924.00 |
| Dec 31, 2023 | 19,685.00 |
| Sep 30, 2023 | 19,521.00 |
| Jun 30, 2023 | 17,628.00 |
| Mar 31, 2023 | 17,628.00 |
| Dec 31, 2022 | 17,628.00 |
| Sep 30, 2022 | 17,628.00 |
| Jun 30, 2022 | 17,473.00 |
| Mar 31, 2022 | 17,409.00 |
| Nov 30, 2021 | 11,080.00 |
| Aug 31, 2021 | 7,685.00 |
| May 31, 2021 | 9,527.00 |
| Feb 28, 2021 | 6,991.00 |
| Nov 30, 2020 | 4,205.00 |
| Aug 31, 2020 | 1,526.00 |
| May 31, 2020 | 1,537.00 |
| Feb 29, 2020 | 1,411.00 |
API Access
Artelo Biosciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ARTL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "ARTL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=ARTL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();